- Previous close
36.05 - Open
36.11 - Bid 36.87 x 51000
- Ask 37.30 x 28900
- Day's range
36.11 - 37.30 - 52-week range
31.02 - 38.60 - Volume
74,298 - Avg. Volume
113,024 - Market cap (intra-day)
7.261B - Beta (5Y monthly) 0.26
- PE ratio (TTM)
24.22 - EPS (TTM)
1.54 - Earnings date 20 Aug 2024
- Forward dividend & yield 1.23 (3.30%)
- Ex-dividend date 29 Aug 2024
- 1y target est
39.48
EBOS Group Limited engages in the marketing, wholesale, and distribution of healthcare, medical, pharmaceutical, and animal care products in Australia, Southeast Asia, and New Zealand. It operates through Healthcare and Animal Care segments. The company provides healthcare logistics; medication management solutions; pharmacy management software; loyalty, generics, compliance, business intelligence, and store software services; and health communications, programs, and consultancy services. It also offers community based health care services and programs; vitamins, minerals and supplements, herbal and fruit teas, and natural toothpastes, as well as functional foods, including molasses and manuka honey; Pharmacy Choice, a five step integrated retail program for independent pharmacies; and healthSAVE, a community pharmacy banner that helps members drive their retail businesses. In addition, the company supplies health and wellness products to public and private hospitals, day surgeries, general practice, aged care facilities, specialist clinics, government, and non-profit health agencies, as well as clinically essential products; and provides pharmacy services to private and public hospitals, cancer centers, correctional facilities, and veterinary clinics. Further, it offers allografts solutions; healthcare distribution, warehousing, clinical trial management, and product registration services; clinical trial logistics; aesthetic healthcare devices, medical-grade cosmeceuticals, and injectables; and surgical devices and medical consumables. Additionally, the company provides pet nutrition, treats, clean-up, and grooming products and accessories; and wholesales veterinary products for companion animals, production animals, and equine athletes. The company was formerly known as Early Bros Dental & Surgical Supplies Ltd. and changed its name to EBOS Group Limited in 1986. EBOS Group Limited was incorporated in 1922 and is headquartered in Docklands, Australia.
www.ebosgroup.com4,150
Full-time employees
30 June
Fiscal year ends
Healthcare
Sector
Medical Distribution
Industry
Recent news: EBO.NZ
View more
Performance overview: EBO.NZ
Trailing total returns as of 8/11/2024, which may include dividends or other distributions. Benchmark is
.YTD return
1-year return
3-year return
5-year return
Compare to: EBO.NZ
Select to analyse similar companies using key performance metrics; select up to four stocks.
Statistics: EBO.NZ
View moreValuation measures
Market cap
7.26B
Enterprise value
8.82B
Trailing P/E
24.16
Forward P/E
27.17
PEG ratio (5-yr expected)
--
Price/sales (ttm)
0.50
Price/book (mrq)
2.71
Enterprise value/revenue
0.61
Enterprise value/EBITDA
13.56
Financial highlights
Profitability and income statement
Profit margin
2.06%
Return on assets (ttm)
4.58%
Return on equity (ttm)
11.57%
Revenue (ttm)
21.13B
Net income avi to common (ttm)
434.97M
Diluted EPS (ttm)
1.54
Balance sheet and cash flow
Total cash (mrq)
357.84M
Total debt/equity (mrq)
67.93%
Levered free cash flow (ttm)
19.04M